New diabetes clinical trial: Dapagliflozin for Long COVID Syndrome

Published on: April 01, 2025 at 11:00PM
Conditions: COVID - 19; Long COVID Syndrome
Interventions: Drug: Dapagliflozin (DAPA); Drug: Placebo
Sponsors: Ottawa Heart Institute Research Corporation
Not yet recruiting
https://ift.tt/louYL8J